District of Columbia Center for AIDS Research (Dev Core)

$344,019P30FY2024AINIH

George Washington University, Washington DC

Investigators

Linked publications & trials

Paper 39556546 Paper 39457713 Paper 39408681 Paper 39401241 Paper 39339899 Paper 39303435 Paper 39302204 Paper 39149467 Paper 39115957 Paper 39078714 Paper 39078391 Paper 39052698 Paper 39016173 Paper 38905477 Paper 38793665 Paper 38743239 Paper 38741181 Paper 38669268 Paper 38562877 Paper 38539112 Paper 38538156 Paper 38528590 Paper 38474837 Paper 38429000 Paper 38329558 Paper 38319460 Paper 38318349 Paper 38314604 Paper 38306927 Paper 38285293 Paper 38245684 Paper 38232978 Paper 38228564 Paper 38169349 Paper 38146952 Paper 38123897 Paper 38085100 Paper 38042947 Paper 37961332 Paper 37942865 Paper 37922262 Paper 37843371 Paper 37766318 Paper 37712704 Paper 37707857 Paper 37707856 Paper 37707855 Paper 37707854 Paper 37707853 Paper 37707852 Paper 37707851 Paper 37707850 Paper 37707849 Paper 37707848 Paper 37707847 Paper 37707846 Paper 37707845 Paper 37707844 Paper 37707843 Paper 37707842 Paper 37707841 Paper 37523048 Paper 37498198 Paper 37461333 Paper 37401992 Paper 37352497 Paper 37333330 Paper 37286190 Paper 37167318 Paper 37161481 Paper 37078025 Paper 37063856 Paper 36924258 Paper 36835589 Paper 36807246 Paper 36799942 Paper 36736722 Paper 36625855 Paper 36598172 Paper 36563749 Paper 36525226 Paper 36517984 Paper 36477652 Paper 36454825 Paper 36398676 Paper 36371695 Paper 36352294 Paper 36143170 Paper 36108251 Paper 36103150 Paper 36068482 Paper 35984609 Paper 35939181 Paper 35932569 Paper 35874772 Paper 35805220 Paper 35790614 Paper 35763745 Paper 35763725 Paper 35579000

Abstract

PROJECT SUMMARY The aims and activities DC CFAR Pathway Program are aligned with and enhances those of the Developmental Core. The goal and activities of both the Pathway Program and Developmental Core work synergistically to develop a community of HIV researchers that supports diversity, dynamic mentorship, interdisciplinary researchers that now spans from HS through early stage and transitioning investigators.

View original record on NIH RePORTER →